IL6 and amyotrophic lateral sclerosis: As compared to controls treated with physiological saline, both types of antibodies decreased the rate of GSH efflux from hepatocytes (Table 3), thus proving, in two different models, that IL6 is a main cytokine responsible for the increase in hepatic GSH efflux during ALS progression.